Cargando…
HCV Glycoprotein Structure and Implications for B-Cell Vaccine Development
Despite the approval of highly efficient direct-acting antivirals in the last decade Hepatitis C virus (HCV) remains a global health burden and the development of a vaccine would constitute an important step towards the control of HCV. The high genetic variability of the viral glycoproteins E1 and E...
Autores principales: | Ströh, Luisa J., Krey, Thomas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7555785/ https://www.ncbi.nlm.nih.gov/pubmed/32947858 http://dx.doi.org/10.3390/ijms21186781 |
Ejemplares similares
-
Conformational Flexibility in the CD81-Binding Site of the Hepatitis C Virus Glycoprotein E2
por: Ströh, Luisa J., et al.
Publicado: (2018) -
Viral Glycoproteins Induce NLRP3 Inflammasome Activation and Pyroptosis in Macrophages
por: Eisfeld, Hannah S., et al.
Publicado: (2021) -
HCV Kinetic Models and Their Implications in Drug Development
por: Nguyen, THT, et al.
Publicado: (2015) -
Structural and Biophysical Characterization of the HCV E1E2 Heterodimer for Vaccine Development
por: Toth, Eric A., et al.
Publicado: (2021) -
From Structural Studies to HCV Vaccine Design
por: Yechezkel, Itai, et al.
Publicado: (2021)